◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › K › KLINIQ

The Klinique Medical Clinic Public Company Limited (KLINIQ) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Cyclical · Personal Services · DATA UPDATED 2026-08-22

The Klinique Medical Clinic Public Company Limited (KLINIQ) operates in the Personal Services industry and is headquartered in Bangkok, Thailand. Its market capitalization is roughly THB 7 billion. In the fiscal year ended 2025-12-31, KLINIQ reported THB 3.6B in revenue and THB 364M in net income.

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand.

Interactive charts & full statements →

KLINIQ Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	THB 3.6B	THB 3.0B	THB 2.3B	THB 1.6B	—
Gross Profit	THB 1.8B	THB 1.5B	THB 1.2B	THB 923M	—
Operating Income (EBIT)	THB 477M	THB 399M	THB 345M	THB 256M	—
Net Income	THB 364M	THB 322M	THB 289M	THB 206M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KLINIQ Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	THB 1.1B	THB 1.0B	THB 878M	THB 851M	THB 814M
Gross Profit	THB 560M	THB 518M	THB 433M	THB 432M	THB 413M
Operating Income (EBIT)	THB 160M	THB 145M	THB 104M	THB 118M	THB 110M
Net Income	THB 121M	THB 111M	THB 79M	THB 89M	THB 85M

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KLINIQ Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(THB 319M)	(THB 308M)	(THB 231M)	(THB 153M)	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KLINIQ Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	THB 0M	(THB 154M)	—	—	THB 0M

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KLINIQ Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	THB 3.3B	THB 3.1B	THB 2.8B	THB 2.6B	—
Total Liabilities	THB 1.6B	THB 1.4B	THB 1.1B	THB 944M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KLINIQ viewer.

Other Companies in Personal Services

2485 · Tear Corporation — JPY 11 billion
4331 · Take and Give. Needs Co., Ltd — JPY 10 billion
9160 · ON THE PAGE, Inc. — JPY 8 billion
2437 · Shinwa Wise Holdings Co.,Ltd. — JPY 7 billion
1448 · Fu Shou Yuan International Group Limited — HK$6 billion
7040 · Sun-Life Holding Co.,Ltd. — JPY 6 billion
7127 · Ikka Holdings Co.,Ltd. — JPY 5 billion
SPA · Siam Wellness Group Public Company Limited — THB 4 billion

← KLIN All “K” companies KLIP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.